Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma

Br J Haematol. 2012 May;157(4):412. doi: 10.1111/j.1365-2141.2012.09090.x. Epub 2012 Mar 13.

Authors

Yuji Hirata¹, Taiji Yokote, Uta Nishiwaki, Motomu Tsuji, Toshiaki Hanafusa

Affiliation

¹ Department of Internal Medicine, Osaka Medical College, Takatsuki City, Osaka, Japan.

PMID: 22409317
DOI: 10.1111/j.1365-2141.2012.09090.x

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cyclophosphamide / adverse effects
Cyclophosphamide / therapeutic use
Doxorubicin / adverse effects
Doxorubicin / therapeutic use
Fatal Outcome
Female
Humans
Inappropriate ADH Syndrome / complications*
Inappropriate ADH Syndrome / diagnosis*
Inappropriate ADH Syndrome / therapy
Lymphoma, Primary Cutaneous Anaplastic Large Cell / complications*
Lymphoma, Primary Cutaneous Anaplastic Large Cell / diagnosis*
Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy
Neoplasm Staging
Prednisone / adverse effects
Prednisone / therapeutic use
Skin Neoplasms / complications*
Skin Neoplasms / diagnosis*
Skin Neoplasms / drug therapy
Sodium Chloride / administration & dosage
Sodium Chloride / therapeutic use
Vincristine / adverse effects
Vincristine / therapeutic use

Substances

Sodium Chloride
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

CHOP protocol